Posterior reversible encephalopathy syndrome and oral methotrexate.
Department of Medicine, Altnagelvin Hospital, Londonderry, Northern Ireland BT47 6SB, UK.
Caroline
C
Hart
Michael O
MO
Kinney
Mark O
MO
McCarron
D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D001772:Blood Cell Count; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000927:Anticonvulsants; D018501:Antirheumatic Agents; D010672:Phenytoin; D008727:Methotrexate